Eyeworld

56 AAO Program Preview • November 11–14, 2017 EW AAO 2017 by Liz Hillman EyeWorld Staff Writer Following a break for lunch, afternoon offerings will cover MIGS, new frontiers in glaucoma research, IOP monitoring, and glaucoma-cat- aract controversies. MIGS presenta- tions are set to begin at 1:31 p.m. and will cover canal-based surgery (including stenting and non-stent- ing forms), surgery in the supracho- roidal space, and ab interno subcon- junctival approaches. "The Edge of Cutting Edge—The Frontiers of Glaucoma Research" from 2:28–3:12 p.m. will feature the role of ocular biomechanics in understanding glaucoma, possible environmental risks for glaucoma, in vivo imaging of retinal ganglion cells, gene therapy, stem cells, and more. From 3:42–4:16 p.m., the focus will be on "All Things IOP." The ef- fect of circadian factors on glaucoma progression will be discussed along with innovations in tonometry and controlling IOP. The last section of Glaucoma Subspecialty Day will involve several case presentations focused on cata- ract controversies. These will include "Still Narrow After Laser Peripheral Iridotomy—Is Clear Lens Extraction on the Table?," "Premium IOLs in Glaucoma Patients—The Role of Toric and Presbyopia Correcting Lenses," "Cataract in Pseudoexfoli- ation: IOL Type, Capsular Tension Ring, Role of Femtosecond Laser," and "IOL Selection With Post-Trab Hypotony—How to Choose the Best Fit?" "There's so much new technol- ogy coming out that I think this is a banner year for glaucoma. I think there's a lot of excitement related to that, and we're going to be address- ing all of those issues in our subspe- cialty day," Dr. Lin said. EW Contact information Lin: Shan.Lin@ucsf.edu "This section is one that partic- ipants won't want to miss," Dr. Lin said. The next section from 9:07–9:58 a.m. will cover the latest in diagnos- tics, including the best approach for diagnosing early glaucoma, artifacts and non-glaucomatous abnormali- ties in OCT, and the role of imaging and perimetry in severe glaucoma, among other related topics. "Inflammation Nation—Uveitic and Steroid Glaucoma Diagnosis and Management" will run from 10:28–11:23 a.m., with several case presentations followed by panel discussions. The American Glaucoma Society Subspecialty Day Lecture will be de- livered by Kuldev Singh, MD, Palo Alto, California, on "The Glaucoma Renaissance." "This is an exciting year for glaucoma. We have so many new drugs that will be approved and new technologies, including MIGS procedures, that have recently been approved. There are also novel advances for delivering medications that can improve compliance and minimize side effects," said Dr. Lin, who is co-chairing the program with Jody Piltz-Seymour, MD, Philadelphia. Dr. Lin said attendees will hear a key talk from Gary Novack, PhD, San Rafael, California, who will deliver a lecture on "New Molecules in Clinical Development," during the opening session on new thera- peutics and delivery systems. Other topics that will be discussed during the section that starts at 8:00 a.m. include herbs and supplements, intra- and extraocular drug delivery, and punctal plug drug delivery. Subspecialty day to provide in-depth look at the latest in glaucoma "E xciting" is how Shan Lin, MD, director of the glaucoma service, Department of Ophthalmology, University of Cali- fornia, San Francisco, described the program for Glaucoma Subspecialty Day at the 2017 American Academy of Ophthalmology (AAO) annual meeting, taking place on Saturday, November 11. Hosted with the American Glau- coma Society, Glaucoma Subspecial- ty Day will showcase the latest in diagnostic capabilities, therapeutics, drug delivery systems, microinvasive glaucoma surgery (MIGS), and more. October 2017 From diagnostics to therapeutics and surgery, Glaucoma Subspecialty Day will cover it all D avid Karcher, ASCRS executive director, will be presented with the Distinguished Service Award during the Opening Session at the 2017 American Academy of Ophthalmology annual meeting in New Orleans. Congratulations to David Karcher

• Blank Page
• Blank Page (1)